Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 4, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 27 August 2026 - 15:00

Human medicines European public assessment report (EPAR): Bilprevda, denosumab, Date of authorisation: 17/09/2025, Revision: 4, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/bilprevda

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters